000 01145 a2200325 4500
005 20250516145755.0
264 0 _c20130618
008 201306s 0 0 eng d
022 _a1474-1784
024 7 _a10.1038/nrd3979
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSimon, Richard
245 0 0 _aImplementing personalized cancer genomics in clinical trials.
_h[electronic resource]
260 _bNature reviews. Drug discovery
_cMay 2013
300 _a358-69 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aClassification
650 0 4 _aClinical Trials as Topic
650 0 4 _aGenomics
650 0 4 _aHumans
650 0 4 _aMolecular Biology
650 0 4 _aMolecular Diagnostic Techniques
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aPrecision Medicine
_xtrends
650 0 4 _aResearch Design
700 1 _aRoychowdhury, Sameek
773 0 _tNature reviews. Drug discovery
_gvol. 12
_gno. 5
_gp. 358-69
856 4 0 _uhttps://doi.org/10.1038/nrd3979
_zAvailable from publisher's website
999 _c22710518
_d22710518